Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引:0
|
作者
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
关键词
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients
    Qiu, Xiao-Yan
    Jiao, Zheng
    Zhang, Ming
    Zhong, Long-Jin
    Liang, Hui-Qi
    Ma, Chun-Lai
    Zhang, Liang
    Zhong, Ming-Kang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (11) : 1069 - 1084
  • [2] ASSOCIATION OF CYP3A4*18B POLYMORPHISMS WITH THE PHARMACOKINETICS OF TACROLIMUS IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Li Danying
    Fang Yun
    Teng Ruichen
    PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 250 - 252
  • [3] Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients
    Feng Qiu
    Xiao-Jing He
    Ya-Xin Sun
    Jesse Li-Ling
    Li-Mei Zhao
    Pharmacological Reports, 2011, 63 : 815 - 825
  • [4] Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients
    Xin, Hua-wen
    Liu, Hui-ming
    Li, Yuan-qi
    Huang, Hui
    Zhang, Li
    Yu, Ai-rong
    Wu, Xiao-chun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (06) : 497 - 503
  • [5] Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients
    Qiu, Feng
    He, Xiao-Jing
    Sun, Ya-Xin
    Li-Ling, Jesse
    Zhao, Li-Mei
    PHARMACOLOGICAL REPORTS, 2011, 63 (03) : 815 - 825
  • [6] ASSOCIATION OF CYP3A4☆18B AND CYP3A5☆3 POLYMORPHISM WITH CYCLOSPORINE-RELATED LIVER INJURY IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Xin, H.
    Yu, A.
    Wu, X.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 60 - 60
  • [7] Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation
    Hu, Yong-Fang
    Qiu, Wen
    Liu, Zhao-Qian
    Zhu, Li-Jun
    Liu, Zhong-Qi
    Tu, Jiang-Hua
    Wang, Dan
    Li, Zhi
    He, Jun
    Zhong, Gan-Ping
    Zhou, Gan
    Zhou, Hong-Hao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (11) : 1093 - 1098
  • [8] Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients
    Zochowska, Dorota
    Wyzgal, Janusz
    Paczek, Leszek
    ANNALS OF TRANSPLANTATION, 2012, 17 (03) : 36 - 44
  • [9] IMPACT OF CYP3A5, CYP3A4 AND MDR1 GENE POLYMORPHISMS ON TROUGH CONCENTRATIONS OF TACROLIMUS, CYCLOSPORINE AND SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Shi, Yunying
    Li, Yi
    Cai, Bei
    Cai, Bei
    Zou, Yuangao
    Tao, Ye
    Wang, Lanlan
    TRANSPLANT INTERNATIONAL, 2013, 26 : 84 - 84
  • [10] Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects
    Hu, Y.-F.
    Tu, J.-H.
    Tan, Z.-R.
    Liu, Z.-Q.
    Zhou, G.
    He, J.
    Wang, D.
    Zhou, H.-H.
    XENOBIOTICA, 2007, 37 (03) : 315 - 327